Article
Six years' experience with LipidSeq: clinical and research learnings from a hybrid, targeted sequencing panel for dyslipidemias.
BMC medical genomics - 10 Feb 2020
Dron Jacqueline S, Wang Jian, McIntyre Adam D, Iacocca Michael A, Robinson John F, Ban Matthew R, Cao Henian, Hegele Robert A
Abstract excerpt
BACKGROUND: In 2013, our laboratory designed a targeted sequencing panel, "LipidSeq", to study the genetic determinants of dyslipidemia and metabolic disorders. Over the last 6 years, we have analyzed 3262 patient samples obtained from our own Lipid Genetics Clinic and international colleagues. Here, we highlight our findings and discuss research benefits and clinical implications of our panel. METHODS: LipidSeq...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.